CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Innate Pharma SA

IPHA
$168MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for IPHA. That does not mean none is planned.

Get an email about IPHA's next catalysts

Track Innate Pharma (IPHA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)πŸ‡ΊπŸ‡ΈNorth AmericaMARSEILLE174 employees
Drug Pipeline

Frequently asked questions

What is in Innate Pharma SA's drug pipeline?β†’

CatalystAlert tracks 6 drug candidates in Innate Pharma SA's (IPHA) pipeline across Phase 2. Its lead program is IPH2101 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Innate Pharma SA's next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Innate Pharma SA (IPHA) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track IPHA biotech catalysts?β†’

Add IPHA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Innate Pharma SA's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply